The changing pattern of epidemiology in hepatocellular carcinoma.
about
Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude miceMolecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesEpidemiology of Hepatocellular Carcinoma in the Asia-Pacific RegionMicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinomaThe short-lived African turquoise killifish: an emerging experimental model for ageingDifferentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-AnalysisImmunology of hepatocellular carcinomaAssociation between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysisQuality of life and hepatocellular carcinomaPrevalence of Hepatitis B Co-Infection among HIV Positive Patients: Narrative Review ArticleRole of innate immunity in the development of hepatocellular carcinomaProfile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to dateTargeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patientsThe intestinal barrier as an emerging target in the toxicological assessment of mycotoxinsTherapeutic potential of the translation inhibitor silvestrol in hepatocellular cancerThe Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 DiabetesControlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs.Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology NursesVirus-induced hepatocellular carcinoma with special emphasis on HBV.Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine.Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Selection and management of hepatocellular carcinoma patients with sorafenib: recommendations and opinions from an Italian liver unit.Stabilization and augmentation of circulating AIM in mice by synthesized IgM-Fc.Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.Current management of hepatocellular carcinoma.350-560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma: The safety and efficacyAlpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients.Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: a 25-year study.GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosisTrend of hepatocellular carcinoma incidence after Bayesian correction for misclassified data in Iranian provinces.Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-reviewBioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosisFibrosis-dependent mechanisms of hepatocarcinogenesisData mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma.Transcatheter arterial chemoembolization for intermediate-stage hepatocellular carcinoma: clinical outcome and safety in elderly patientsCan TIE-2 expressing monocytes represent a novel marker for hepatocellular carcinoma?DNA repair gene XRCC1 Arg194Trp polymorphism and susceptibility to hepatocellular carcinoma: A meta-analysisEpidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysisMICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma.
P2860
Q21245479-C23A1B18-70DD-4849-9A09-0EAB534AC346Q26745338-B3C82841-F67F-44D3-A5FA-7C586C131A21Q26750444-C4D8B6C4-2A5D-411E-8D02-7B6468254A7AQ26751392-AD5B55FB-DDF5-451B-AE10-A7C9AC65F00BQ26770155-ADD293C5-EFDD-47DF-A52F-17BD0406850DQ26772319-479DE6D9-2DC8-4BCA-BAEF-7112B6CC1081Q26777560-C8A411F9-9EAA-4D5B-A2C7-07D11CEE82F8Q26795411-9F4DEB2B-E934-4A52-A243-B31733530EC7Q26801941-75B11F76-EFA0-4530-B3EE-06214CAD15B7Q26825504-B68D68B9-FD4A-4B1D-9E01-FA626D790945Q26852495-154C6561-C70A-44C5-B30C-D53383A5B4B1Q27024780-64468D17-1F3D-4BB7-9822-A47665C1E1EEQ28071589-7643ACCC-999B-46B7-89FB-0EF282617291Q28085015-F4504A9E-43E8-49C2-B5D9-5FBB4A0F56C1Q28277155-0C3D32CE-3F2E-4802-8067-F1D7D949CBB9Q28533823-ED5DA738-7A41-463B-9A4A-BE8AA1A059B1Q28546913-6D750F97-853A-47DD-8122-FBBD78123115Q30226462-73F83349-6EF9-4C8B-8547-C34EDA3EB2AFQ30234460-C0901066-F9F6-41EA-BA37-10C21FF92681Q30238961-1C78E31F-66B7-4D37-8849-F389C40DDC86Q30301218-2DACFAA4-8BC2-4F3E-A7BE-013E3B065DE1Q30391932-4CE0F5CF-9637-48E3-ACFE-B012DC8BA9EDQ30486078-CB8CBCD9-F894-4DBE-AE91-8BCF66592F66Q31160559-F85341B3-750A-44B1-9F6A-1C2237E06372Q33407547-40307105-F85B-4702-9824-0B28ADC9D86CQ33582165-0C412CE5-3B77-4D5D-ACAE-9B4AF4AD333DQ33606153-98774344-2DC1-4488-BDA1-1BAAE941CD39Q33614172-C45242CC-6B7D-4182-8A98-9BF984DB5ABBQ33621731-C1F3DAA2-C3A5-4C39-A87E-1B5BE075A33BQ33638516-890256AC-31B3-4CFD-AE3F-C807698DA067Q33716197-1FCBF7C1-A63F-4F2D-B7FE-1DD1ADFCF1B6Q33731768-13B905A7-0A8B-4FFB-8108-4BBCC0AEAFCCQ33833557-79D52265-8B15-4AAA-89A6-F64B95D96598Q33865082-0D35078E-A1C4-40A0-B7B8-D031507F6924Q33875631-14ECA756-07CF-4C20-BF9E-0FFCD7A1DDF2Q33935237-1C36283D-94CD-43E9-883A-4C11DE7DD5AEQ34077177-54CF80B5-4BA6-4C92-A0C5-F28741B881ECQ34141393-B5D12196-01B7-45B0-A7DC-CFED0D8C6CCCQ34189361-0050B6E3-BD91-4DF2-A314-7089F0968A82Q34241771-EA1804C7-4382-4060-B733-0DC983E75DC4
P2860
The changing pattern of epidemiology in hepatocellular carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The changing pattern of epidemiology in hepatocellular carcinoma.
@ast
The changing pattern of epidemiology in hepatocellular carcinoma.
@en
type
label
The changing pattern of epidemiology in hepatocellular carcinoma.
@ast
The changing pattern of epidemiology in hepatocellular carcinoma.
@en
prefLabel
The changing pattern of epidemiology in hepatocellular carcinoma.
@ast
The changing pattern of epidemiology in hepatocellular carcinoma.
@en
P2093
P2860
P1476
The changing pattern of epidemiology in hepatocellular carcinoma.
@en
P2093
Donna L White
Hashem B El-Serag
Helena Nordenstedt
P2860
P304
P356
10.1016/S1590-8658(10)60507-5
P478
42 Suppl 3
P577
2010-07-01T00:00:00Z